XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · IEX Real-Time Price · USD
2.705
+0.275 (11.32%)
Jul 22, 2024, 11:26 AM EDT - Market open
XTL Biopharmaceuticals Employees
As of December 31, 2016, XTL Biopharmaceuticals had 7 total employees, including 2 full-time and 5 part-time employees. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$254,571
Market Cap
14.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | 7 | 1 | 16.67% |
| Dec 31, 2015 | 6 | 1 | 20.00% |
| Dec 31, 2014 | 5 | -7 | -58.33% |
| Dec 31, 2013 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 225 |
| Star Equity Holdings | 171 |
| Psychemedics | 116 |
| Flora Growth | 108 |
| Evaxion Biotech | 49 |
| BriaCell Therapeutics | 16 |
| Talphera | 15 |
| Kiora Pharmaceuticals | 12 |
XTLB News
- 6 weeks ago - XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewsWire
- 4 months ago - XTL To Aquire The Social Proxy - GlobeNewsWire
- 9 months ago - XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel - GlobeNewsWire
- 9 months ago - XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 3 years ago - Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting - PRNewsWire